Principal Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $178M | Buy |
6,339,372
+32,564
| +0.5% | +$867K | 0.1% | 196 |
|
|
2025
Q4 | $157M | Buy |
6,306,808
+169,048
| +3% | +$4.26M | 0.08% | 215 |
|
|
2025
Q3 | $156M | Sell |
6,137,760
-52,625
| -0.9% | -$1.3M | 0.08% | 217 |
|
|
2025
Q2 | $150M | Sell |
6,190,385
-181,263
| -3% | -$4.23M | 0.08% | 215 |
|
|
2025
Q1 | $161M | Sell |
6,371,648
-32,231
| -0.5% | -$843K | 0.09% | 200 |
|
|
2024
Q4 | $170M | Sell |
6,403,879
-2,684,440
| -30% | -$72.8M | 0.09% | 193 |
|
|
2024
Q3 | $263M | Sell |
9,088,319
-1,349,308
| -13% | -$39.4M | 0.14% | 142 |
|
|
2024
Q2 | $292M | Sell |
10,437,627
-657,172
| -6% | -$18.1M | 0.17% | 122 |
|
|
2024
Q1 | $308M | Sell |
11,094,799
-47,467
| -0.4% | -$1.32M | 0.18% | 119 |
|
|
2023
Q4 | $321M | Sell |
11,142,266
-693,695
| -6% | -$21M | 0.2% | 109 |
|
|
2023
Q3 | $393M | Sell |
11,835,961
-72,872
| -0.6% | -$2.58M | 0.28% | 83 |
|
|
2023
Q2 | $437M | Buy |
11,908,833
+218,037
| +2% | +$8.49M | 0.3% | 80 |
|
|
2023
Q1 | $477M | Buy |
11,690,796
+97,672
| +0.8% | +$4.22M | 0.34% | 69 |
|
|
2022
Q4 | $594M | Sell |
11,593,124
-185,484
| -2% | -$8.89M | 0.45% | 49 |
|
|
2022
Q3 | $515M | Buy |
11,778,608
+3,751
| +0% | +$182K | 0.41% | 54 |
|
|
2022
Q2 | $617M | Buy |
11,774,857
+566,590
| +5% | +$28.9M | 0.46% | 46 |
|
|
2022
Q1 | $580M | Buy |
11,208,267
+185,005
| +2% | +$9.6M | 0.37% | 61 |
|
|
2021
Q4 | $650M | Sell |
11,023,262
-1,546,449
| -12% | -$76.6M | 0.39% | 54 |
|
|
2021
Q3 | $541M | Buy |
12,569,711
+801,981
| +7% | +$35.5M | 0.35% | 60 |
|
|
2021
Q2 | $461M | Buy |
11,767,730
+426,033
| +4% | +$16.6M | 0.3% | 82 |
|
|
2021
Q1 | $411M | Sell |
11,341,697
-549,449
| -5% | -$19.5M | 0.29% | 89 |
|
|
2020
Q4 | $438M | Sell |
11,891,146
-1,446,387
| -11% | -$53.1M | 0.32% | 83 |
|
|
2020
Q3 | $464M | Sell |
13,337,533
-798,743
| -6% | -$28M | 0.39% | 58 |
|
|
2020
Q2 | $439M | Buy |
14,136,276
+619,112
| +5% | +$21M | 0.39% | 59 |
|
|
2020
Q1 | $419M | Sell |
13,517,164
-32,581
| -0.2% | -$1.11M | 0.46% | 45 |
|
|
2019
Q4 | $504M | Sell |
13,549,745
-314,468
| -2% | -$11.2M | 0.42% | 45 |
|
|
2019
Q3 | $473M | Sell |
13,864,213
-316,835
| -2% | -$11.5M | 0.42% | 47 |
|
|
2019
Q2 | $583M | Sell |
14,181,048
-855,518
| -6% | -$34M | 0.52% | 32 |
|
|
2019
Q1 | $606M | Sell |
15,036,566
-512,762
| -3% | -$20.5M | 0.56% | 27 |
|
|
2018
Q4 | $644M | Sell |
15,549,328
-567,183
| -4% | -$23.5M | 0.69% | 18 |
|
|
2018
Q3 | $674M | Sell |
16,116,511
-549,350
| -3% | -$21.1M | 0.59% | 23 |
|
|
2018
Q2 | $574M | Buy |
16,665,861
+713,556
| +4% | +$24.4M | 0.53% | 28 |
|
|
2018
Q1 | $537M | Buy |
15,952,305
+157,200
| +1% | +$5.4M | 0.51% | 29 |
|
|
2017
Q4 | $543M | Buy |
15,795,105
+193,736
| +1% | +$6.61M | 0.5% | 29 |
|
|
2017
Q3 | $528M | Buy |
15,601,369
+196,877
| +1% | +$6.33M | 0.51% | 28 |
|
|
2017
Q2 | $491M | Buy |
15,404,492
+4,916,770
| +47% | +$155M | 0.49% | 29 |
|
|
2017
Q1 | $340M | Sell |
10,487,722
-1,660,513
| -14% | -$52.4M | 0.41% | 47 |
|
|
2016
Q4 | $374M | Sell |
12,148,235
-2,763,233
| -19% | -$84.4M | 0.47% | 36 |
|
|
2016
Q3 | $479M | Buy |
14,911,468
+460,250
| +3% | +$15.4M | 0.63% | 21 |
|
|
2016
Q2 | $483M | Sell |
14,451,218
-3,311,669
| -19% | -$106M | 0.67% | 16 |
|
|
2016
Q1 | $500M | Buy |
17,762,887
+503,791
| +3% | +$14.4M | 0.72% | 10 |
|
|
2015
Q4 | $529M | Buy |
17,259,096
+2,242,040
| +15% | +$70.5M | 0.79% | 11 |
|
|
2015
Q3 | $448M | Buy |
15,017,056
+140,827
| +0.9% | +$4.52M | 0.7% | 12 |
|
|
2015
Q2 | $473M | Sell |
14,876,229
-2,698,078
| -15% | -$87.9M | 0.71% | 11 |
|
|
2015
Q1 | $580M | Sell |
17,574,307
-699,324
| -4% | -$22.2M | 0.86% | 8 |
|
|
2014
Q4 | $540M | Buy |
18,273,631
+1,499,885
| +9% | +$43M | 0.84% | 7 |
|
|
2014
Q3 | $471M | Buy |
16,773,746
+1,214,481
| +8% | +$34.1M | 0.8% | 9 |
|
|
2014
Q2 | $438M | Buy |
15,559,265
+1,033,640
| +7% | +$29.5M | 0.74% | 9 |
|
|
2014
Q1 | $443M | Buy |
14,525,625
+3,853,016
| +36% | +$115M | 0.79% | 8 |
|
|
2013
Q4 | $310M | Sell |
10,672,609
-141,950
| -1% | -$4.13M | 0.58% | 15 |
|
|
2013
Q3 | $295M | Buy |
10,814,559
+1,173,435
| +12% | +$31.9M | 0.61% | 15 |
|
|
2013
Q2 | $256M | Buy |
+9,641,124
| New | +$266M | 0.57% | 20 |
|
Other funds holding PFE
VCM
VPM
Principal Financial Group's PFE Position: Q1 2026 in Review
Principal Financial Group increased its Pfizer (PFE) stake by 0.52% in Q1 2026, buying an estimated $867K and bringing the position to 6,339,372 shares worth $178M. The position accounts for 0.1% of the portfolio, ranked #196.
Principal Financial Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $674M in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Principal Financial Group held 6,339,372 shares of Pfizer worth $178M as of Q1 2026.
- Principal Financial Group bought 32,564 Pfizer shares in Q1 2026, an estimated $867K.
- Pfizer made up 0.1% of Principal Financial Group's portfolio in Q1 2026, its #196 holding.
- Principal Financial Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Principal Financial Group's Pfizer position peaked at $674M in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.